
![]()
Media releases
Welcome to the Novartis Vaccines press room. You can find copies of our latest press releases, Novartis Vaccines links, contact information and general details about the Novartis Vaccines business unit. Our team of international communications professionals is always available to help meet the information needs of the news media around the world. We hope that you find these materials useful and encourage you to contact us directly if further details are required. Thank you for your interest in Novartis Vaccines.
For further information please do not hesitate to contact us.
nvd.communications@novartis.com
2009
21-Dec-09
18-Dec-09
24-Nov-09
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
17-Nov-09
13-Nov-09
05-Nov-09
06-Oct-09
Novartis completes shipment of US supply of Fluvirin® seasonal influenza vaccine
25-Sep-09
Novartis A(H1N1) Pandemic Influenza vaccine Focetria® receives positive opinion from CHMP
03-Sep-09
05-Aug-09
01-Jul-09
12-Jun-09
04-Jun-09
Novartis announces typhoid vaccine research program in partnership with the Wellcome Trust
26-May-09
30-Apr-09
28-Apr-09
02-Apr-09
Ixiaro® vaccine receives Marketing Authorization in Europe
(56 KB)
30-Mar-2009
Ixiaro® receives FDA approval for the prevention of Japanese Encephalitis
(70 KB)
26-Feb-2009
Novartis Vaccines Statement
Following the Medicine and Healthcare Products Regulatory Agency Drug Alert issued at 5pm yesterday Novartis Vaccines continues to work with the MHRA to recall specific lots of the Meningitis C vaccine – Menjugate Kit. These being Lot 236011 and Lot 235012A that were both distributed in the UK.
This is purely a precautionary measure as the lots distributed passed all routine checks before release. However, parents who are still concerned should contact their GP or NHS Direct. Novartis initiated this rapid precautionary recall because patient safety is our utmost concern and we are committed to being a safe and reliable provider of vaccines.
For further information please contact the Novartis Vaccines UK Press Office on:
+44 (0)1276 698567
15-Jan-2009
Influenza

Learn out how the influenza vaccine is created.
Corporate Citizenship

Corporate citizenship rests on four pillars: patients, business conduct, people & communities, environmental care.